nView s1 completes first 25 cases at leading pediatric hospitals

Salt Lake City, UT - March 15th, 2021.

The nView s1, nView medical’s breakthrough imaging system, has now been used in 25 cases at three leading pediatric hospitals: Children’s National Hospital, Lucile Packard Children’s Hospital Stanford, and Texas Scottish Rite Hospital for Children. Nine surgeons across the three pilot hospitals have used nView’s insta-3D™ technology to-date; in pediatric spinal deformity, microdiscectomy, and extremity procedures.

Shannon Kelly, M.D., Associate Chief of Orthopaedic Surgery and Sports Medicine at Children’s National, has utilized the nView s1 for spinal implant verification in five cases.

“Imaging technology has evolved over the years and with innovative systems like this, we can look at 3D images instantaneously during a procedure, which could potentially improve patient care and outcomes,” says Dr. Kelly.

nView medical’s CEO, Cristian Atria, commented on reaching the milestone of 25 cases.

“We couldn’t have had better clinical partners for the initial use of our technology. Our pilot sites are leaders in pediatric care: they provide the highest quality care and are at the forefront of technology. The collaboration with our pilot sites has been extremely valuable to confirm the value proposition of nView’s breakthrough imaging technology. The level of equipment utilization across multiple surgeons and now across multiple applications signals the broad applicability of this technology and its ease of adoption.” 

About nView medical:

nView medical, based in Salt Lake City, UT, is a startup whose mission is to make surgery safer, faster, and consistently accurate. nView develops imaging systems, bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery. nView medical backers include; the National Science Foundation (NSF), the National Institutes of Health (NIH), the State Of Utah, the National Consortium for Pediatric Device Innovation, MedTech Innovator, Dr. Kevin Foley, MD, and Fusion Fund.